Hormonal regulation of liver cytochrome P450 enzymes

Cytochrome P450: Structure, Mechanism, and Biochemistry: Third edition

Volumn , Issue , 2005, Pages 347-376

  Waxman, David J ^a   Chang, Thomas K H ^b  

^a USA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892351224     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-27447-2_9     Document Type: Chapter

References (241)

1. Kato, R. (1974). Sex-related differences in drug metabolism. Drug Metab. Rev. 3, 1-32.
2. Kato, R. (1977). Drug metabolism under pathological and abnormal physiological states in animals and man. Xenobiotica 7, 25-92.
3. Skett, P. (1987). Hormonal regulation and sex differences of xenobiotic metabolism. Prog. Drug. Metab. 10, 85-139.
4. Davies, D. S., P. L. Gigon, and J. R. Gillette (1969). Species and sex differences in electron transport systems in liver microsomes and their relationship to ethylmorphine demethylation. Life Sci. 8, 85-91.
5. Gurtoo, H. L. and N. B. Parker (1976). Organ specificity of the sex dependent regulation of aryl hydrocarbon hydroxylase (AHH) in rat. Biochem. Biophys. Res. Commun. 11, 216-222.
6. Kato, R. and J. R. Gillette (1965). Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes. J. Pharmacol. Exp. Ther. 150, 285-291.
7. Guengerich, F. P. (1987). Enzymology of rat liver cytochromes P450. In F. P. Guengerich (ed.), Mammalian Cytochromes P450, Vol. 1. CRC Press, Boca Raton, FL, pp. 1-54.
8. Ryan, D. E. and W. Levin (1990). Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther. 45, 153-239.
9. Nelson, D. R. (2003). Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution. Arch. Biochem. Biophys. 409, 18-24.
10. Nelson, D. R., L. Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman et al. (1996). P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42.
11. Waxman, D. J. (1988). Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem. Pharmacol. 37, 71-84.
12. Beierle, I., B. Meibohm, and H. Derendorf (1999). Gender differences in pharmacokinetics and pharmacodynamics. Int. J. Clin. Pharmacol. Ther. 37, 529-547.
13. Schwartz, J. B. (2003). The influence of sex on pharmacokinetics. Clin. Pharmacokinet. 42, 107-121.
14. Tanaka, E. (1999). Gender-related differences in pharmacokinetics and their clinical significance. J. Clin. Pharm. Ther. 24, 339-346.
15. Harris, R. Z., L. Z. Benet, and J. B. Schwartz (1995). Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50, 222-239.
16. Meibohm, B., I. Beierle, and H. Derendorf (2002). How important are gender differences in pharmacokinetics? Clin. Pharmacokinet. 41, 329-342.
17. Hunt, C. M., W. R. Westerkam, and G. M. Stave (1992). Effect of age and gender on the activity of human hepatic CYP3A. Biochem. Pharmacol. 44, 275-283.
18. Zaphiropoulos, P. G., A. Mode, G. Norstedt, and J. A. Gustafsson (1989). Regulation of sexual differentiation in drug and steroid metabolism. Trends Pharmacol. Sci. 10, 149-153.
19. Waxman, D. J. (1984). Rat hepatic cytochrome P-450 isoenzyme 2c. Identification as a male-specific, developmentally induced steroid 16 alpha-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. J. Biol. Chem. 259, 15481-15490.
20. Morgan, E. T., C. MacGeoch, and J.-A. Gustafsson (1985). Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16alpha-hydroxylase cytochrome P-450 apoprotein in the rat. J. Biol. Chem. 260, 11895-11898.
21. Waxman, D. J., G. A. Dannan, and F. P. Guengerich (1985). Regulation of rat hepatic cytochrome P-450: Age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 24, 4409-4417.
22. MacGeoch, C., E. T. Morgan, and J. A. Gustafsson (1985). Hypothalamo-pituitary regulation of cytochrome P-450 (15) beta apoprotein levels in rat liver. Endocrinology 117, 2085-2092.
23. Nelson, D. R., T. Kamataki, D. J. Waxman, F. P. Guengerich, R. W. Estabrook, R. Feyereisen et al. (1993). The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12, 1-51.
24. Waxman, D. J. (1992). Regulation of liver-specific steroid metabolizing cytochromes P450: Cholesterol 7alpha-hydroxylase, bile acid 6beta-hydroxylase, and growth hormone-responsive steroid hormone hydroxylases. J. Steriod Biochem. Mol. Biol. 43, 1055-1072.
25. Nagata, K., N. Murayama, M. Miyata, M. Shimada, A. Urahashi, Y. Yamazoe et al. (1996). Isolation and characterization of a new rat P450 (CYP3A18) cDNA encoding P450 (6) beta-2 catalyzing testosterone 6 beta- and 16 alpha-hydroxylations. Pharmacogenetics 6, 103-111.
26. Wang, H., K. L. Napoli, and H. W. Strobel (2000). Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones. Mol. Cell. Biochem. 213, 127-135.
27. Waxman, D. J., G. A. Le Blanc, J. J. Morrissey, J. Staunton, and D. P. Lapenson (1988). Adult malespecific and neonatally programmed rat hepatic P-450 forms RLM2 and 2a are not dependent on pulsatile plasma growth hormone for expression. J. Biol. Chem. 263, 11396-11406.
28. McClellan, G. P., P. Linko, H. N. Yeowell, and J. A. Goldstein (1989). Hormonal regulation of male-specific rat hepatic cytochrome P-450g (P-450IIC13) by androgens and the pituitary. J. Biol. Chem. 264, 18960-18965.
29. Dannan, G. A., F. P. Guengerich, and D. J. Waxman (1986). Hormonal regulation of rat liver microsomal enzymes. Role of gonadal steroids in programming, maintenance, and suppression of delta 4-steroid 5 alpha-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450. J. Biol. Chem. 261, 10728-10735.
30. Yamazoe, Y., X. Ling, N. Murayama, D. Gong, K. Nagata, and R. Kato (1990). Modulation of hepatic level of microsomal testosterone 7 alphahydroxylase, P-450a (P450IIA), by thyroid hormone and growth hormone in rat liver. J. Biochem. (Tokyo) 108, 599-603.
31. Ram, P. A. and D. J. Waxman (1990). Pretranslational control by thyroid hormone of rat liver steroid 5 alpha-reductase and comparison to the thyroid dependence of two growth hormoneregulated CYP2C mRNAs. J. Biol. Chem. 265, 19223-19229.
32. Sundseth, S. S. and D. J. Waxman (1992). Sexdependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J. Biol. Chem. 267, 3915-3921.
33. Waxman, D. J., P. A. Ram, G. Notani, G. A. Le Blanc, J. A. Alberta, J. J. Morrissey et al. (1990). Pituitary regulation of the male-specific steroid 6 betahydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppressive influence of growth hormone and thyroxine acting at a pretranslational level. Mol. Endocrinol. 4, 447-454.
34. Ram, P. A. and D. J. Waxman (1991). Hepatic P450 expression in hypothyroid rats: Differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (IIC11), and RLM2 (IIA2) to thyroid hormone. Mol. Endocrinol. 5, 13-20.
35. McClellan, G. P., D. J. Waxman, M. Caveness, and J. A. Goldstein (1987). Phenotypic differences in expression of cytochrome P-450g but not its mRNA in outbred male Sprague-Dawley rats. Arch. Biochem. Biophys. 253, 13-25.
36. Thummel, K. E., L. V. Favreau, J. E. Mole, and J. B. Schenkman (1988). Further characterization of RLM2 and comparison with a related form of cytochrome P450, RLM2b. Arch. Biochem. Biophys. 266, 319-333.
37. Bandiera, S., D. E. Ryan, W. Levin, and P. E. Thomas (1986). Age- and sex-related expression of cytochromes P450f and P450g in rat liver. Arch. Biochem. Biophys. 248, 658-676.
38. Kawai, M., S. M. Bandiera, T. K. H. Chang, and G. D. Bellward (2000). Growth hormone regulation and developmental expression of rat hepatic CYP3A18, CYP3A9, and CYP3A2. Biochem. Pharmacol. 59, 1277-1287.
39. Gonzalez, F. J., B. J. Song, and J. P. Hardwick (1986). Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: Gene conversion and differential regulation. Mol. Cell. Biol. 6, 2969-2976.
40. Sonderfan, A. J., M. P. Arlotto, D. R. Dutton, S. K. McMillen, and A. Parkinson (1987). Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 255, 27-41.
41. Yamazoe, Y., N. Murayama, M. Shimada, K. Yamauchi, K. Nagata, S. Imaoka et al. (1988). A sex-specific form of cytochrome P-450 catalyzing propoxycoumarin O-depropylation and its identity with testosterone 6 beta-hydroxylase in untreated rat livers: Reconstitution of the activity with microsomal lipids. J. Biochem. (Tokyo) 104, 785-790.
42. Gonzalez, F. J., S. Kimura, B. J. Song, J. Pastewka, H. V. Gelboin, and J. P. Hardwick (1986). Sequence of two related P-450 mRNAs transcriptionally increased during rat development. An R.dre.l sequence occupies the complete 3' untranslated region of a liver mRNA. J. Biol. Chem. 261, 10667-10672.
43. Leo, M. A., S. Iida, and C. S. Lieber (1984). Retinoic acid metabolism by a system reconstituted with cytochrome P-450. Arch. Biochem. Biophys. 234, 305-312.
44. Mahnke, A., D. Strotkamp, P. H. Roos, W. G. Hanstein, G. G. Chabot, and P. Nef (1997). Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch. Biochem. Biophys. 337, 62-68.
45. Colby, H. D. (1980). Regulation of hepatic drug and steroid metabolism by androgens and estrogens. Adv. Sex Horm. Res. 4, 27-71.
46. Arlotto, M. P. and A. Parkinson (1989). Identification of cytochrome P450a (P450IIA1) as the principal testosterone 7 alpha-hydroxylase in rat liver microsomes and its regulation by thyroid hormones. Arch. Biochem. Biophys. 270, 458-471.
47. De Waziers, I., P. H. Cugnenc, C. S. Yang, J. P. Leroux, and P. H. Beaune (1990). Cytochrome P-450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 253, 387-394.
48. Friedberg, T., P. Siegert, M. A. Grassow, B. Bartlomowicz, and F. Oesch (1990). Studies of the expression of the cytochrome P450IA, P450IIB, and P450IIC gene family in extrahepatic and hepatic tissues. Environ. Health Perspect. 88, 67-70.
49. Chen, G. F., M. J. Ronis, R. E. Thomas, D. J. Flint, and T. M. Badger (1997). Hormonal regulation of microsomal cytochrome P450 2C11 in rat liver and kidney. J. Pharmacol. Exp. Ther. 283, 1486-1494.
50. Fujita, S., R. Morimoto, M. Chiba, K. Kitani and T. Suzuki (1989). Evaluation of the involvement of a male specific cytochrome P-450 isozyme in senescence-associated decline of hepatic drug metabolism in male rats. Biochem. Pharmacol. 38, 3925-3931.
51. Robinson, R. C., K. Nagata, H. V. Gelboin, J. Rifkind, F. J. Gonzalez, and F. K. Friedman (1990). Developmental regulation of hepatic testosterone hydroxylases: Simultaneous activation and repression of constitutively expressed cytochromes P450 in senescent rats. Arch. Biochem. Biophys. 277, 42-46.
52. Dhir, R. N., W. Dworakowski, and B. H. Shapiro (2002). Middle-age alterations in the sexually dimorphic plasma growth hormone profiles: Involvement of growth hormone-releasing factor and effects on cytochrome p450 expression. Drug Melab. Dispos. 30, 141-147.
53. Shimada, M., N. Murayama, Y. Yamazoe, T. Kamataki, and R. Kato (1987). Further studies on the persistence of neonatal androgen imprinting on sex-specific cytochrome P-450, testosterone and drug oxidations. Jpn. J. Pharmacol. 45, 467-478.
54. Einarsson, K., J. A. Gustafsson, and A. Stenberg (1973). Neonatal imprinting of liver microsomal hydroxylation and reduction of steroids. J. Biol. Chem. 248, 4987-4997.
55. Gustafsson, J. A., A. Mode, G. Norstedt, and P. Skett (1983). Sex steroid induced changes in hepatic enzymes. Annu. Rev. Physiol. 45, 51-60.
56. Bandiera, S. and C. Dworschak (1992). Effects of testosterone and estrogen on hepatic levels of cytochromes P450 2C7 and P450 2C11 in the rat. Arch. Biochem. Biophys. 296, 286-295.
57. Cadario, B. J., G. D. Bellward, S. Bandiera, T. K. H. Chang, W. W. W. Ko, E. Lemieux et al. (1992). Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats. Mol. Pharmacol. 41, 981-988.
58. Janeczko, R., D. J. Waxman, G. A. Le Blanc, A. Morville, and M. Adesnik (1990). Hormonal regulation of levels of the messenger RNA encoding hepatic P450 2c (IIC11), a constitutive male-specific form of cytochrome P450. Mol. Endocrinol. 4, 295-303.
59. Ribeiro, V. and M. C. Lechner (1992). Cloning and characterization of a novel CYP3A1 allelic variant: Analysis of CYP3A1 and CYP3A2 sex-hormonedependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch. Biochem. Biophys. 293, 147-152.
60. Chang, T. K. H. and G. D. Bellward (1996). Peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11 and steroid 5 alphareductase: Pretranslational regulation and impact on microsomal drug activation. J. Pharmacol. Exp. Ther. 278, 1383-1391.
61. Anderson, M. D., S. M. Bandiera, T. K. H. Chang, and G. D. Bellward (1998). Effect of androgen administration during puberty on hepatic CYP2C11, CYP3A, and CYP2A1 expression in adult female rats. Drug Metab. Dispos. 26, 1031-1038.
62. Waxman, D. J., J. J. Morrissey, and G. A. Le Blanc (1989). Female-predominant rat hepatic P-450 forms j (IIE1) and 3 (IIA1) are under hormonal regulatory controls distinct from those of the sex-specific P-450 forms. Endocrinology 124, 2954-2966.
63. Sasamura, H., K. Nagata, Y. Yamazoe, M. Shimada, T. Saruta and R. Kato (1990). Effect of growth hormone on rat hepatic cytochrome P-450f mRNA: A new mode of regulation. Mol. Cell Endocrinol. 68, 53-60.
64. Mode, A. and G. Norstedt (1982). Effects of gonadal steroid hormones on the hypothalamc-pituitary-liver axis in the control of sex differences in hepatic steroid metabolism in the rat. J. Endocrinol. 95, 181-187.
65. Jansson, J. O. and L. A. Frohman (1987). Differential effects of neonatal and adult androgen exposure on the growth hormone secretory pattern in male rats. Endocrinology 120, 1551-1557.
66. Jansson, J. O. and L. A. Frohman (1987). Inhibitory effect of the ovaries on neonatal androgen imprinting of growth hormone secretion in female rats. Endocrinology 121, 1417-1423.
67. Jansson, J.-O., S. Ekberg, and O. Isaksson (1985). Sexual dimorphism in the control of growth hormone secretion. Endocr. Rev. 6, 128-150.
68. Kamataki, T., M. Shimada, K. Maeda, and R. Kato (1985). Pituitary regulation of sex-specific forms of cytochrome P-450 in liver microsomes of rats. Biochem. Biophys. Res. Commun. 130, 1247-1253.
69. Le Blanc, G. A. and D. J. Waxman (1990). Regulation and ligand-binding specificities of two sex-specific bile acid-binding proteins of rat liver cytosol. J. Biol. Chem. 265, 5654-5661.
70. Wang, H. and H. W. Strobel (1997). Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch. Biochem. Biophys. 344, 365-372.
71. Kawai, M., S. M. Bandiera, T. K. H. Chang, F. M. Poulet, P. M. Vancutsem, and G. D. Bellward (1999). Modulation of hepatic CYP2A1, CYP2C11, and CYP3A9 expression in adult rats by neonatal administration of tamoxifen. Drug Metab. Dispos. 27, 1392-1398.
72. Carlsson, L., E. Eriksson, H. Seeman, and J. O. Jansson (1987). Oestradiol increases baseline growth hormone levels in the male rat: Possible direct action on the pituitary. Acta Physiol. Scand. 129, 393-399.
73. Waxman, D. J., N. A. Pampori, P. A. Ram, A. K. Agrawal, and B. H. Shapiro (1991). Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc. Natl. Acad. Sci. USA 88, 6868-6872.
74. Eden, S. (1979). Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinology 105, 555-560.
75. Tannenbaum, G. S., J. B. Martin, and E. Colle (1976). Ultradian growth hormone rhythm in the rat: Effects of feeding, hyperglycemia, and insulin-induced hypoglycemia. Endocrinology 99, 720-727.
76. Tannenbaum, G. S. and J. B. Martin (1976) Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 98, 562-570.
77. MacLeod, J. N., N. A. Pampori, and B. H. Shapiro (1991). Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J. Endocrinol. 131, 395-399.
78. Asplin, C. M., A. C. Faria, E. C. Carlsen, V. A. Vaccaro, R. E. Barr, A. Iranmanesh et al. (1989). Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 69, 239-245.
79. Winer, L. M., M. A. Shaw, and G. Baumann (1990). Basal plasma growth hormone levels in man: New evidence for rhythmicity of growth hormone secretion. J. Clin. Endocrinol. Metab. 70, 1678-1686.
80. Pincus, S. M., E. F. Gevers, I. C. Robinson, G. Van Den Berg, F. Roelfsema, M. L. Hartman et al. (1996). Females secrete growth hormone with more process irregularity than males in both humans and rats. Am. J. Physiol. 270, E107-E215.
81. Veldhuis, J. D. (1996). Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur. J. Endocrinol. 134, 287-295.
82. Ho, K. Y., W. S. Evans, R. M. Blizzard, J. D. Veldhuis, G. R. Merriam, E. Samojlik et al. (1987). Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J. Clin. Endocrinol. Metab. 64, 51-58.
83. Kato, R., Y. Yamazoe, M. Shimada, N. Murayama, and T. Kamataki (1986). Effect of growth hormone and ectopic transplantation of pituitary gland on sex-specific forms of cytochrome P450 and testosterone and drug oxidations in rat liver. J. Biochem. 100, 895-902.
84. Noshiro, M. and M. Negishi (1986). Pretranslational regulation of sex-dependent testosterone hydroxylases by growth hormone in mouse liver. J. Biol. Chem. 261, 15923-15927.
85. Sueyoshi, T., N. Yokomori, K. S. Korach, and M. Negishi (1999). Developmental action of estrogen receptor-alpha feminizes the growth hormone-Stat5b pathway and expression of Cyp2a4 and Cyp2d9 genes in mouse liver. Mol. Pharmacol. 56, 473-477.
86. Shapiro, B. H., A. K. Agrawal, and N. A. Pampori (1995). Gender differences in drug metabolism regulated by growth hormone. Int. J. Biochem. Cell Biol. 27, 9-20.
87. Cheung, N. W., C. Liddle, S. Coverdale, J. C. Lou, and S. C. Boyages (1996). Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man. J. Clin. Endocrinol. Metab. 81, 1999-2001.
88. Berglund, E., G. Johannsson, O. Beck, B. A. Bengtsson, and A. Rane (2002). Growth hormone replacement therapy induces codeine clearance. Eur. J. Clin. Invest. 32, 507-512.
89. Jurgens, G., K. H. Lange, L. O. Reuther, B. B. Rasmussen, K. Brosen, and H. R. Christensen (2002). Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Clin. Pharmacol. Ther. 71, 162-168.
90. 2 breath test. Dev. Pharmacol. Ther. 12, 90-95.
91. Redmond, G. P., J. J. Bell, P. S. Nichola, and J. M. Perel (1980). Effect of growth hormone on human drug metabolism: time course and substrate specificity. Pediatr. Pharmacol. 1, 63-70.
92. Jaffe, C. A., D. K. Turgeon, K. Lown, R. Demott-Friberg, and P. B. Watkins (2002). Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am. J. Physiol. Endocrinol. Metab. 283, E1008-E1015.
93. Rasmussen, E., B. Ask, N. Finnstrom, A. Skottner-Lundin, and A. Rane (1998). Insulin-like growth factor 1 (IGF-I) effects on sex-specific cytochrome P450 enzymes in normal and hypophysectomised male rats. Biochem. Pharmacol. 56, 459-466.
94. Robertson, G. R., G. C. Farrell, and C. Liddle (1998). Sexually dimorphic expression of rat CYP3A9 and CYP3A18 genes is regulated by growth hormone. Biochem. Biophys. Res. Commun. 242, 57-60.
95. MacGeoch, C., E. T. Morgan, B. Cordell, and J. A. Gustafsson (1987). Growth hormone regulates expression of rat liver cytochrome P-450 15 beta at a pretranslational level. Biochem. Biophys. Res. Commun. 143, 782-788.
96. Pampori, N. A. and B. H. Shapiro (1994). Subnormal concentrations in the feminine profile of circulating growth hormone enhance expression of female-specific CYP2C12. Biochem. Pharmacol. 47, 1999-2004.
97. Pampori, N. A. and B. H. Shapiro (1996). Feminization of hepatic cytochrome P450s by nominal levels of growth hormone in the feminine plasma profile. Mol. Pharmacol. 50, 1148-1156.
98. Pampori, N. A. and B. H. Shapiro (1999). Gender differences in the responsiveness of the sexdependent isoforms of hepatic P450 to the feminine plasma growth hormone profile. Endocrinology 140, 1245-1254.
99. Chang, T. K. H., M. M. Y. Chan, S. L. Holsmer, S. M. Bandiera, and G. D. Bellward (1996). Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase. Biochem. Pharmacol. 51, 357-368.
100. Waxman, D. J., P. A. Ram, N. A. Pampori, and B. H. Shapiro (1995). Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: Induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol. Pharmacol. 48, 790-797.
101. Agrawal, A. K. and B. H. Shapiro (2001). Intrinsic signals in the sexually dimorphic circulating growth hormone profiles of the rat. Mol. Cell Endocrinol. 173, 167-181.
102. Shapiro, B. H., N. A. Pampori, D. P. Lapenson, and Waxman D. J. (1994). Growth hormone-dependent and -independent sexually dimorphic regulation of phenobarbital-induced hepatic cytochromes P450 2B1 and 2B2. Arch. Biochem. Biophys. 312, 234-239.
103. Yamazoe, Y., M. Shimada, N. Murayama, and R. Kato (1987). Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. J. Biol. Chem. 262, 7423-7428.
104. Shapiro, B. H., J. N. MacLeod, N. A. Pampori, J. J. Morrissey, D. P. Lapenson, and D. J. Waxman (1989). Signalling elements in the ultradian rhythm of circulating growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450. Endocrinology 125, 2935-2944.
105. Yamazoe, Y., M. Shimada, N. Murayama, K. Yamauchi, and R. Kato (1988). Alteration of hepatic drug metabolizing activities and contents of cytochrome P-450 isozymes by neonatal monosodium glutamate treatment. Biochem. Pharmacol. 37, 1687-1691.
106. Shapiro, B. H., N. A. Pampori, P. A. Ram, and D. J. Waxman (1993). Irreversible suppression of growth hormone-dependent cytochrome P450 2C11 in adult rats neonatally treated with monosodium glutamate. J. Pharmacol. Exp. Ther. 265, 979-984.
107. Pampori, N. A. and B. H. Shapiro (1994). Overexpression of CYP2C11, the major male-specific form of hepatic cytochrome P450, in the presence of nominal pulses of circulating growth hormone in adult male rats neonatally exposed to low levels of monosodium glutamate. J. Pharmacol. Exp. Ther. 271, 1067-1073.
108. Pampori, N. A. and B. H. Shapiro (2000). Nominal growth hormone pulses in otherwise normal masculine plasma profiles induce intron retention of overexpressed hepatic CYP2C11 with associated nuclear splicing deficiency. Endocrinology 141, 4100-4106.
109. Agrawal, A. K. and B. H. Shapiro (2000). Differential expression of gender-dependent hepatic isoforms of cytochrome P-450 by pulse signals in the circulating masculine episodic growth hormone profile of the rat. J. Pharmacol. Exp. Ther. 292, 228-237.
110. Pampori, N. A., A. K. Agrawal, and B. H. Shapiro (2001). Infusion of gender-dependent plasma growth hormone profiles into intact rats: Effects of subcutaneous, intraperitoneal, and intravenous routes of rat and human growth hormone on endogenous circulating growth hormone profiles and expression of sexually dimorphic hepatic CYP isoforms. Drug Metab. Dispos. 29, 8-16.
111. Waxman, D. J., J. J. Morrissey, J. N. MacLeod, and B. H. Shapiro (1990). Depletion of serum growth hormone in adult female rats by neonatal monosodium glutamate treatment without loss of female-specific hepatic enzymes P450 2d (IIC12) and steroid 5 alpha-reductase. Endocrinology 126, 712-720.
112. Toilet, P., B. Enberg, and A. Mode (1990). Growth hormone (GH) regulation of cytochrome P-450IIC12, insulin-like growth factor-I (IGF-I), and GH receptor messenger RNA expression in primary rat hepatocytes: A hormonal interplay with insulin, IGF-I, and thyroid hormone. Mol. Endocrinol. 4, 1934-1942.
113. Sundseth, S. S., J. A. Alberta, and D. J. Waxman (1992). Sex-specific, growth hormone-regulated transcription of the cytochrome P450 2C11 and 2C12 genes. J. Biol. Chem. 267, 3907-3914.
114. Legraverend, C., A. Mode, S. Westin, A. Strom, H. Eguchi, P. G. Zaphiropoulos et al. (1992). Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol. Endocrinol. 6, 259-266.
115. Morishima, N., H. Yoshioka, Y. Higashi, K. Sogawa, and Y. Fujii-Kuriyama (1987). Gene structure of cytochrome P450 (M-l) specifically expressed in male rat liver. Biochemistry. 26, 8279-8285.
116. Zaphiropoulos, P. G., A. Strom, J. A. Robertson, and J. A. Gustafsson (1990). Structural and regulatory analysis of the male-specific rat liver cytochrome P-450 g: Repression by continuous growth hormone administration. Mol. Endocrinol. 4, 53-58.
117. Waxman, D. J., S. Zhao, and H. K. Choi (1996). Interaction of a novel sex-dependent, growth hormoneregulated liver nuclear factor with CYP2C12 promoter. J. Biol. Chem. 271, 29978-29987.
118. Strom, A., H. Eguchi, A. Mode, P. Toilet, P. E. Stromstedt, and J. Gustafson (1994). Characterization of the proximal promoter and two silencer elements in the CYP2C gene expressed in rat liver. DNA Cell Biol. 13, 805-819.
119. Guzelian, P. S., D. Li, E. G. Schuetz, P. Thomas, W. Levin, A. Mode et al. (1988). Sex change in cytochrome P-450 phenotype by growth hormone treatment of adult rat hepatocytes maintained in a culture system on matrigel. Proc. Natl. Acad. Sci. USA 85, 9783-9787.
120. Baxter, R. C. and Z. Zaltsman (1984). Induction of hepatic receptors for growth hormone (GH) and prolactin by GH infusion is sex independent. Endocrinology 115, 2009-2014.
121. Bick, T., Z. Hochberg, T. Amit, O. G. Isaksson, and J. O. Jansson (1992). Roles of pulsatility and continuity of growth hormone (GH) administration in the regulation of hepatic GH-receptors, and circulating GH-binding protein and insulin-like growth factor-I. Endocrinology 131, 423-429.
122. Legraverend, C., A. Mode, T. Wells, I. Robinson, and J. A. Gustafsson (1992). Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. FASEB J. 6, 711-718.
123. Leung, D. W., S. A. Spencer, G. Cachianes, R. G. Hammonds, C. Collins, W. J. Henzel et al. (1987). Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature 330, 537-543.
124. Kelly, P. A., S. Ali, M. Rozakis, L. Goujon, M. Nagano, I. Pellegrini et al. (1993). The growth hormone/prolactin receptor family. Recent Prog. Horm. Res. 48, 123-164.
125. Colosi, P., K. Wong, S. R. Leong, and W. I. Wood (1993). Mutational analysis of the intracellular domain of the human growth hormone receptor. J. Biol. Chem. 268, 12617-12623.
126. De Vos, A. M., M. Ultsch, and A. A. Kossiakoff (1992). Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255, 306-312.
127. Cunningham, B. C., M. Ultsch, A. M. De Vos, M. G. Mulkerrin, K. R. Clauser, and J. A. Wells (1991). Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254, 821-825.
128. Fuh, G., B. C. Cunningham, R. Fukunaga, S. Nagata, D. V. Goeddel, and J. A. Wells (1992). Rational design of potent antagonists to the human growth hormone receptor. Science 256, 1677-1680.
129. Ross, R. J., K. C. Leung, M. Maamra, W. Bennett, N. Doyle, M. J. Waters et al. (2001). Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. J. Clin. Endocrinol. Metab. 86, 1716-1723.
130. Gent, J., P. Van Kerkhof, M. Roza, G. Bu, and G. J. Strous (2002). Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc. Natl. Acad. Sci. USA. 99, 9858-9863.
131. Staten, N. R., J. C. Byatt, and G. G. Krivi (1993). Ligand-specific dimerization of the extracellular domain of the bovine growth hormone receptor. J. Biol. Chem. 268, 18467-18473.
132. Bick, T., M. B. H. Youdim, and Z. Hochberg (1989). Adaptation of liver membrane somatogenic and lactogenic growth hormone (GH) binding to the spontaneous pulsation of GH secretion in the male rat. Endocrinology 125, 1711-1717.
133. Bick, T., M. B. H. Youdim, and Z. Hochberg (1989). The dynamics of somatogenic and lactogenic growth hormone binding: Internalization to Golgi fractions in the male rat. Endocrinology 125, 1718-1722.
134. Strous, G. J. and J. Gent (2002). Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function. FEBS Lett. 529, 102-109.
135. Strous, G. J. and P. Van Kerkhof (2002). The ubiquitin-proteasome pathway and the regulation of growth hormone receptor availability. Mol. Cell. Endocrinol. 197, 143-51.
136. Carter-Su, C., L. Rui, and J. Herrington (2000). Role of the tyrosine kinase JAK2 in signal transduction by growth hormone. Pediatr. Nephrol. 14, 550-557.
137. Waxman, D. J. and S. J. Frank (2000). Growth Hormone Action: Signaling via a JAK/STAT-coupled Receptor. Humana Press, Totowa, pp. 55-83.
138. Finidori, J. (2000). Regulators of growth hormone signaling. Vitam. Horm. 59, 71-97.
139. Waxman, D. J., P. A. Ram, S. H. Park, and H. K. Choi (1995). Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. J. Biol. Chem. 270, 13262-13270.
140. Darnell, J. E., Jr. (1997). STATs and gene regulation. Science 277, 1630-1635.
141. Ram, P. A., S. H. Park, H. K. Choi, and D. J. Waxman (1996). Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J. Biol. Chem. 271, 5929-5940.
142. Choi, H. K. and D. J. Waxman (2000). Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: Developmental regulation and role in male-specific liver gene expression. Endocrinology 141, 3245-3255.
143. Choi, H. K. and D. J. Waxman (1999). Growth hormone, but not prolactin, maintains, low-level activation of STAT5a and STAT5b in female rat liver. Endocrinology 140, 5126-5135.
144. Tannenbaum, G. S., H. K. Choi, W. Gurd, and D. J. Waxman (2001). Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity. Endocrinology 142, 4599-4606.
145. Gebert, C. A., S. H. Park, and D. J. Waxman (1999). Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation. Mol. Endocrinol. 13, 213-227.
146. Udy, G. B., R. P. Towers, R. G. Snell, R. J. Wilkins, S. H. Park, P. A. Ram et al. (1997). Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94, 7239-7244.
147. Davey, H. W., R. J. Wilkins, and D. J. Waxman (1999). STAT5 signaling in sexually dimorphic gene expression and growth patterns. Am. J. Hum. Genet. 65, 959-965.
148. Davey, H. W., S. H. Park, D. R. Grattan, M. J. McLachlan, and D. J. Waxman (1999). STAT5b-deficient mice are growth hormone pulseresistant. Role of STAT5b in sex-specific liver P450 expression. J. Biol. Chem. 274, 35331-35336.
149. Teglund, S., C. McKay, E. Schuetz, J. M. Van Deursen, D. Stravopodis, D. Wang et al. (1998). Stat5a and Stat5b proteins have essential and nonessential, or redundant roles in cytokine responses. Cell 93, 841-850.
150. Park, S. H., X. Liu, L. Hennighausen, H. W. Davey, and D. J. Waxman (1999). Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption. J. Biol. Chem. 274, 7421-7430.
151. Grimley, P. M., F. Dong, and H. Rui (1999). Stat5a and Stat5b: Fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev. 10, 131-57.
152. Park, S. H. and D. J. Waxman (2001). Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3beta: Impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression. J. Biol. Chem. 276, 43031-43039.
153. Subramanian, A., J. Wang, and G. Gil (1998). STAT 5 and NF-Y are involved in expression and growth hormone-mediated sexually dimorphic regulation of cytochrome P450 3A10/lithocholic acid 6betahydroxylase. Nucleic Acids Res. 26, 2173-2178.
154. Lahuna, O., M. Rastegar, D. Maiter, J. P. Thissen, F. P. Lemaigre, and G. G. Rousseau (2000). Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone. Mol. Endocrinol. 14, 285-294.
155. Delesque-Touchard, N., S. H. Park, and D. J. Waxman (2000). Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. Proposed mode! for female specific expression of CYP2C12 in adult rat liver. J. Biol. Chem. 275, 34173-34182.
156. Sasaki, Y., Y. Takahashi, K. Nakayama, and T. Kamataki (1999). Cooperative regulation of CYP2C12 gene expression by STAT5 and liverspecific factors in female rats. J. Biol. Chem. 274, 37117-37124.
157. Akiyama, T. E. and F. J. Gonzalez (2003). Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochim. Biophys. Acta. 1619, 223-234.
158. Lahuna, O., L. Fernandez, H. Karlsson, D. Maiter, F. P. Lemaigre, G. G. Rousseau et al. (1997). Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone. Proc. Natl. Acad. Sci. USA 94, 12309-12313.
159. Buggs, C., N. Nasrin, A. Mode, P. Toilet, H. F. Zhao, J. A. Gustafsson et al. (1998). IRE-ABP (insulin response element-A binding protein), an SRY-like protein, inhibits C/EBPalpha (CCAAT/enhancer-binding protein alpha)-stimulated expression of the sex-specific cytochrome P450 2C12 gene. Mol. Endocrinol. 12, 1294-1309.
160. Tullis, K. M., C. J. Krebs, J. Y. Leung, and D. M. Robins (2000). The regulator of sex-limitation gene, rsl, enforces male-specific liver gene expression by negative regulation. Endocrinology 144, 1854-1860.
161. Helander, H., J. A. Gustafsson, and A. Mode (2002). Possible involvement of truncated signal transducer and activator of transcription-5 in the GH pattern-dependent regulation of CYP2C12 gene expression in rat liver. Mol. Endocrinol. 16, 1598-1611.
162. Gebert, C. A., S. H. Park, and D. J. Waxman (1999). Termination of growth hormone pulse-induced STAT5b signaling. Mol. Endocrinol. 13, 38-56.
163. Ram, P. A. and D. J. Waxman (1999). SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem. 274, 35553-35561.
164. Adams, T. E., J. A. Hansen, R. Starr, N. A. Nicola, D. J. Hilton, and N. Billestrup (1998). Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273, 1285-1287.
165. Ram, P. A. and D. J. Waxman (2000). Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. J. Biol. Chem. 275, 39487-39496.
166. Hochberg, Z., T. Bick, and Z. Harel (1990). Alterations of human growth hormone binding by rat liver membranes during hypo- and hyperthyroidism. Endocrinology 126, 325-329.
167. Samuels, H. H., B. M. Forman, Z. D. Horowitz, and Z. S. Ye (1988). Regulation of gene expression by thyroid hormone. J. Clin. Invest. 81, 957-967.
168. Kaminsky, L. S. and E. P. Guengerich (1985). Cytochrome P450 isozyme/isozyme functional interactions and NADPH-cytochrome P450 reductase concentrations as factors in microsomal metabolism of warfarin. Eur. J. Biochem. 149, 479-489.
169. Miwa, G. T., S. B. West, and A. Y. H. Lu (1978). Studies on the rate-limiting enzyme component in the microsomal monooxygenase system. Incorporation of purified NADPH cytochrome c-reductase and cytochrome P450 into rat liver microsomes. JBC 253, 1921-1929.
170. Waxman, D. J., J. J. Morrissey, and G. A. Le Blanc (1989). Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: Pituitary control of hepatic NADPH cytochrome P-450 reductase. Mol. Pharmacol. 35, 519-525.
171. Ram, P. A. and D. J. Waxman (1992). Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. Regulation by multiple mechanisms. J. Biol. Chem. 261, 3294-3301.
172. Li, H. C., D. Liu, and D. J. Waxman (2001). Transcriptional induction of hepatic NADPH: Cytochrome P450 oxidoreductase by thyroid hormone. Mol. Pharmacol. 59, 987-995.
173. Liu, D. and D. J. Waxman (2002). Post-transcriptional regulation of hepatic NADPH-cytochrome P450 reductase by thyroid hormone: Independent effects on poly (A) tail length and mRNA stability. Mol. Pharmacol. 61, 1089-1096.
174. Apletalina, E. V., H. C. Li, and D. J. Waxman (2003). Evaluation of thyroid hormone effects on liver P450 reductase translation. Arch. Biochem. Biophys. 409, 172-179.
175. Le Blanc, G. A. and D. J. Waxman (1988). Feminization of rat hepatic P-450 expression by cisplatin. Evidence for perturbations in the hormonal regulation of steroid-metabolizing enzymes. J. Biol. Chem. 263, 15732-15739.
176. Le Blanc, G. A., S. S. Sundseth, G. F. Weber, and D. J. Waxman (1992). Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats. Cancer Res. 52, 540-547.
177. Le Blanc, G. A. and D. J. Waxman (1990). Mechanisms of cyclophosphamide action on hepatic P-450 expression. Cancer Res. 50, 5720-5726.
178. Chang, T. K. H. and D. J. Waxman (1993). Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5alphareductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard. Cancer Res. 53, 2490-2497.
179. Maines, M. D. and R. D. Mayer (1985). Inhibition of testicular cytochrome P-450-dependent steroid biosynthesis by cis-platinum. J. Biol. Chem. 260, 6063-6068.
180. Maines, M. D., P. M. Sluss, and M. Iscan (1990). cis-Platinum-mediated decrease in serum testosterone is associated with depression of luteinizing hormone receptors and cytochrome P-450scc in rat testis Endocrinology 126, 2398-2406.
181. McClure, M. T. and I. Stupans, (1995). Hormonal perturbation as a possible mechanism for the alteration of cytochrome P450 by cyclophosphamide. Biochem. Pharmacol. 49, 1827-1836.
182. Yeowell, H. N., D. J. Waxman, A. Wadhera, and J. A. Goldstein (1987). Suppression of the constitutive, male-specific rat hepatic cytochrome P-450 2c and its mRNA by 3, 4, 5, 3', 4', 5'-hexachlorobiphenyl and 3-methylcholanthrene. Mol. Pharmacol. 32, 340-347.
183. Yeowell, H. N., D. J. Waxman, G. A. Le Blanc, P. Linko, and J. A. Goldstein (1989). Suppression of male-specific cytochrome P450 2c and its mRNA by 3, 4, 5, 3', 4', 5'-hexachlorobiphenyI in rat liver is not causally related to changes in serum testosterone. Arch. Biochem. Biophys. 271, 508-514.
184. Chang, T. K. H., H. Chen, and D. J. Waxman (1994). 1-(2-chloroethyl)-3- cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels. Drug Metab. Dispos. 22, 673-679.
185. Kraner, J. C., E. T. Morgan, and J. R. Halpert (1994). Selective suppression of rat hepatic cytochrome P450 2C11 by chloramphenicol. J. Pharmacol. Exp. Ther. 270, 1367-1372.
186. Isogai, M., N. Shimada, T. Kamataki, S. Imaoka, and Y. Funae (1993). Changes in the amounts of cytochromes P450 in rat hepatic microsomes produced by cyclosporin A. Xenobiotica. 23, 799-807.
187. Brunner, L. J., W. M. Bennett, and D. R. Koop (1996). Selective suppression of rat hepatic microsomal activity during chronic cyclosporine nephrotoxicity. J. Pharmacol. Exp. Ther. 277, 1710-1718.
188. Lu, S. K., S. M. Callahan, and L. J. Brunner (2003). Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levels. J. Pharmacol. Exp. Ther. 305, 331-337.
189. Guengerich, F. P., G. A. Dannan, S. T. Wright, M. V. Martin, and L. S. Kaminsky (1982). Purification and characterization of liver microsomal cytochromes P-450: Electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry 21, 6019-6030.
190. Shimada, M., N. Murayama, K. Yamauchi, Y. Yamazoe, and R. Kato (1989). Suppression in the expression of a male-specific cytochrome P450, P450-male: Difference in the effect of chemical inducers on P450-male mRNA and protein in rat livers. Arch. Biochem. Biophys. 270, 578-587.
191. Levin, W., P. E. Thomas, D. E. Ryan, and A. W. Wood (1987). Isozyme specificity of testosterone 7 alpha-hydroxylation in rat hepatic microsomes: Is cytochrome P-450a the sole catalyst? Arch. Biochem. Biophys. 258, 630-635.
192. Afsar, A., C. Lee, and D. S. Riddick (1996). Modulation of the expression on constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil. Can. J. Physiol. Pharmacol. 74, 150-156.
193. Jones, E. J. and D. S. Riddick (1996). Regulation of constitutive rat hepatic cytochromes P450 by 3-methylcholanthrene. Xenobiotica 26, 995-1012.
194. Gustafsson, J. A. and M. Ingelman-Sundberg (1979). Changes in steroid hormone metabolism in rat liver microsomes following administration of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxine (TCDD). Biochem. Pharmacol. 28, 497-9.
195. Safa, B., C. Lee, and D. S. Riddick (1997). Role of the aromatic hydrocarbon receptor in the suppression of cytochrome P-450 2C11 by polycyclic aromatic hydrocarbons. Toxicol. Lett. 90, 163-175.
196. Lee, C. and D. S. Riddick (2000). Transcriptional suppression of cytochrome P450 2C11 gene expression by 3-methylcholanthrene. Biochem. Pharmacol. 59, 1417-1423.
197. Moore, R. W., C. L. Potter, H. M. Theobald, J. A. Robinson, and R. E. Peterson (1985) Androgenic deficiency in male rats treated with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 79, 99-111.
198. Timsit, YE. and D. S. Riddick (2000). Interference with growth hormone stimulation of hepatic cytochrome P4502C11 expression in hypophysectomized male rats by 3-methylcholanthrene. Toxicol. Appl. Pharmacol. 163, 105-14.
199. Timsit, Y. E. and D. S. Riddick (2002). Stimulation of hepatic signal transducer and activator of transcription 5b by GH is not altered by 3-methylcholanthrene. Endocrinology 143, 3284-3294.
200. Riddick, D. S., C. Lee, A. Bhathena, and Y. E. Timsit (2003). The 2001 Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons. Can. J. Physiol. Pharmacol. 81, 59-77.
201. Murray, F. T., J. Orth, G. Gunsalus, J. Weisz, J. B. Li, L. S. Jefferson et al. (1981). The pituitary-testicular axis in the streptozotocin diabetic male rat: Evidence for gonadotroph, Sertoli cell and Leydig cell dysfunction. Int. J. Androl. 4, 265-80.
202. Warren, B. L., R. Pak, M. Finlayson, L. Gontovnick, G. Sunahara, and G. D. Bellward (1983). Differential effects of diabetes on microsomal metabolism of various substrates. Comparison of streptozotocin and spontaneously diabetic Wistar rats. Biochem. Pharmacol. 32, 327-335.
203. Skett, P., R. A. Cochrane, and L. A. Joels (1984). The role of androgens in the effect of diabetes mel-Iitus on hepatic drug metabolism in the male rat. Acta Endocrinol. 107, 506-512.
204. Tannenbaum, G. S. (1981). Growth hormone secretory dynamics in streptozotocin diabetes: Evidence of a role for endogenous circulating somatostatin. Endocrinology 108, 76-82.
205. Thummel, K. E. and J. B. Schenkman (1990). Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. Mol. Pharmacol. 37, 119-129.
206. Shimojo, N., T. Ishizaki, S. Imaoka, Y. Funae, S. Fujii, and K. Okuda (1993). Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochem. Pharmacol. 46, 621-627.
207. Yamazoe, Y., N. Murayama, M. Shimada, K. Yamauchi, and R. Kato (1989). Cytochrome P450 in livers of diabetic rats: Regulation by growth hormone and insulin. Arch. Biochem. Biophys. 268, 567-575.
208. Donahue, B. S. and E. T. Morgan (1990). Effects of vanadate on hepatic cytochrome P-450 expression in streptozotocin-diabetic rats. Drug. Metab. Dispos. 18, 519-526.
209. Favreau, L. V., D. M. Malchoff, J. E. Mole, and J. B. Schenkman (1987). Responses to insulin by two forms of rat hepatic microsomal cytochrome P-450 that undergo major (RLM6) and minor (RLM5b) elevations in diabetes. J. Biol. Chem. 262, 14319-14326.
210. Bellward, G. D., T. Chang, B. Rodrigues, J. H. McNeill, S. Maines, D. E. Ryan et al. (1988). Hepatic cytochrome P-450J induction in the spontaneously diabetic BB rat. Mol. Pharmacol. 33, 140-143.
211. Dong, Z. G., J. Y. Hong, Q. A. Ma, D. C. Li, J. Bullock, F. J. Gonzalez et al. (1988). Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Arch. Biochem. Biophys. 263, 29-35.
212. Ma, Q., G. A. Dannan, F. P. Guengerich, and C. S. Yang (1989). Similarities and differences in the regulation of hepatic cytochrome P-450 enzymes by diabetes and fasting in male rats. Biochem. Pharmacol. 38, 3179-3184.
213. Song, B. J., T. Matsunaga, J. P. Hardwick, S. S. Park, R. L. Veech, C. S. Yang et al. (1987). Stabilization of cytochrome P450J messenger ribonucleic acid in the diabetic rat. Mol. Endocrinol. 1, 542-547.
214. Yamazoe, Y, N. Murayama, M. Shimada, S. Imaoka, Y. Funae, and R. Kato (1989). Suppression of hepatic levels of an ethanolinducible P-450DM/j by growth hormone: Relationship between the increased level of P-450DM/j and depletion of growth hormone in diabetes. Mol. Pharmacol. 36, 716-722.
215. Westin, S., A. Strom, J. A. Gustafsson, and P. G. Zaphiropoulos (1990). Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: Inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression. Mol. Pharmacol. 38, 192-197.
216. Donahue, B. S., L. A. Skottner, and E. T. Morgan (1991). Growth hormone-dependent and -independent regulation of cytochrome P-450 isozyme expression in streptozotocin-diabetic rats. Endocrinology 128, 2065-2076.
217. Barnett, C. R., S. Rudd, P. R. Flatt, and C. Ioannides (1993). Sex differences in the diabetes-induced modulation of rat hepatic cytochrome P450 proteins. Biochem. Pharmacol. 45, 313-319.
218. Barnett, C. R., L. Petrides, J. Wilson, P. R. Flatt, and C. Ioannides (1992). Induction of rat hepatic mixed-function oxidases by acetone and other physiological ketones: Their role in diabetesinduced changes in cytochrome P450 proteins. Xenobiotica 22, 1441-1450.
219. Iber, H., T. Li-Masters, Q. Chen, S. Yu, and E. T. Morgan (2001). Regulation of hepatic cytochrome P450 2C11 via cAMP: Implications for down-regulation in diabetes, fasting, and inflammation. J. Pharmacol. Exp. Ther. 297, 174-180.
220. Murray, M., E. Cantrill, I. Mehta, and G. C. Farrell (1992). Impaired expression of microsomal cytochrome P450 2C11 in choline-deficient rat liver during the development of cirrhosis. J. Pharmacol. Exp. Ther. 261, 373-380.
221. Murray, M., L. Zaluzny, and G. C. Farrell (1986). Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model. Biochem. Pharmacol. 35, 1817-1824.
222. Murray, M., L. Zaluzny, and G. C. Farrell (1987). Impaired androgen 16 alpha-hydroxylation in hepatic microsomes from carbon tetrachloridecirrhotic male rats. Gastroenterology 93, 141-147.
223. Chen, X, M. Murray, C. Liddle, X. M. Jiang, and G. C. Farrell (1995). Downregulation of malespecific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: Importance to reduced hepatic content of cytochrome P450 in cholestasis. Hepatology 22, 580-587.
224. Bastien, M. C., F. Leblond, V. Pichette, and J. P. Villeneuve (2000). Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis. Can. J. Physiol Pharmacol. 78, 912-919.
225. Badger, T. M., M. J. J. Ronis, C. K. Lumpkin, C. R. Valentine, M. Shahare, D. Irby et al. (1993). Effects of chronic ethanol on growth hormone secretion and hepatic cytochrome P450 isozymes of the rat. J. Pharmacol. Exp. Ther. 264, 438-447.
226. Rowlands, J. C., H. Wang, R. Hakkak, M. J. Ronis, H. W. Strobel, and T. M. Badger (2000). Chronic intragastric infusion of ethanol-containing diets induces CYP3A9 while decreasing CYP3A2 in male rats. J. Pharmacol. Exp. Ther. 295, 747-752.
227. Martini, R. and M. Murray (1994). Suppression of the constitutive microsomal cytochrome P450 2C11 in male rat liver during dietary vitamin A deficiency. Biochem. Pharmacol. 48, 1305-1309.
228. Martini, R., A. M. Butler, X. M. Jiang, and M. Murray (1995). Pretranslational down regulation of cytochrome P450 2C11 in vitamin A-deficient male rat liver: Prevention by dietary inclusion of retinoic acid. J. Pharmacol. Exp. Ther. 273, 427-434.
229. Murray, M., R. M. Sefton, K. D. Croft, and A. M. Butler (2001). Differential regulation of endobiotic-oxidizing cytochromes P450 in vitamin A-deficient male rat liver Br. J. Pharmacol. 134, 1487-1497.
230. Murray, M. and A. M. Butler (1999). Pretranslational up-regulation of the hepatic microsomal delta4-3-oxosteroid 5alpha-oxidoreductase in male rat liver by all-trans-retinoic acid. Biochem. Pharmacol. 58, 355-362.
231. Murray, M., A. M. Butler, and C. Agus (1996). Restoration of cytochrome P450 2C11 in vitamin A-deficient rat liver by exogenous androgen. FASEBJ. 10, 1058-1063.
232. Xu, Z., M. Kawai, S. M. Bandiera, and T. K. H. Chang (2001). Influence of dietary zinc deficiency during development on hepatic CYP2C11, CYP2C12, CYP3A2, CYP3A9, and CYP3A18 expression in postpubertal male rats. Biochem. Pharmacol. 62, 1283-1291.
233. Manjgaladze, M., S. Chen, L. T. Frame, J. E. Seng, P. H. Duffy, R. J. Feuers et al. (1993). Effects of caloric restriction on rodent drug and carcinogen metabolizing enzymes: Implications for mutagenesis and cancer. Mutat. Res. 295, 201-222.
234. Cheesman, M. J. and P. E. Reilly (1998). Differential inducibility of specific mRNA corresponding to five CYP3A isoforms in female rat liver by RU486 and food deprivation: Comparison with protein abundance and enzymic activities. Biochem. Pharmacol. 56, 473-481.
235. Clarke, L. and D. J. Waxman (1989). Oxidative metabolism of cyclophosphamide: Identification of the hepatic monooxygenase catalysts of drug activation. Cancer Res. 49, 2344-2350.
236. Weber, G. F. and D. J. Waxman (1993). Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes. Biochem. Pharmacol. 45, 1685-1694.
237. Sladek, N. E. (1988). Metabolism of oxazaphosphorines. Pharmacol. Ther. 37, 301-355.
238. Le Blanc, G. A., P. W. Kantoff, S. F. Ng, E. Frei 3rd, and D. J. Waxman (1992). Hormonal perturbations in patients with testicular cancer treated with cisplatin. Cancer 69, 2306-2310.
239. Rouer, E., A. Lemoine, T. Cresteil, P. Rouet, and J. P. Leroux (1987). Effects of genetically or chemically induced diabetes on imipramine metabolism. Respective involvement of flavin monooxygenase and cytochrome P450-dependent monooxygenases. Drug Metab. Dispos. 15, 524-528.
240. Dixon, R. L., L. G. Hart, and J. R. Fouts (1961). The metabolism of drugs by liver microsomes from alloxan-diabetic rats. J. Pharmacol. Exp. Ther. 133, 7-11.
241. Ioannides, C, S. L. Bass, A. D. Ayrton, J. Trinick, R. Walker, and P. R. Flatt (1988). Streptozotocininduced diabetes modulates the metabolic activation of chemical carcinogens. Chem. Biol. Interact. 68, 189-202.